CTT Pharmaceutical Holdings, Inc.
Other OTCTotal Valuation
CTT Pharmaceutical Holdings, Inc. carries a market capitalization of 1.36M, placing it among publicly traded companies globally. Its enterprise value stands at 4.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.36M |
| Enterprise Value | 4.00M |
Share Statistics
CTT Pharmaceutical Holdings, Inc. currently has 59.72M shares outstanding.
| Shares Outstanding | 59.72M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.52 |
| P/TBV Ratio | -143.22 |
| P/FCF Ratio | -67.57 |
| P/OCF Ratio | -63.33 |
Enterprise Valuation
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 4.76 |
Financial Position
CTT Pharmaceutical Holdings, Inc. maintains a current ratio of 0.20, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.20 |
| Quick Ratio | 0.20 |
| Debt / Equity | 45.58 |
| Debt / EBITDA | -0.09 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -347.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
CTT Pharmaceutical Holdings, Inc.'s stock has gained approximately 84.05797% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 84.05797% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.07 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -202,540.00, while operating income came in at -209,075.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -209,075.00 |
| Pretax Income | -211,037.00 |
| Net Income | -211,037.00 |
| EBITDA | -202,540.00 |
| EBIT | -209,075.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
CTT Pharmaceutical Holdings, Inc. holds 7,089.00 in cash and equivalents against 18,814.00 in total debt, resulting in a net debt position of 11,725.00. Total book value stands at -7.63M, with working capital of -27,829.00 providing operational flexibility.
| Cash & Cash Equivalents | 7,089.00 |
| Total Debt | 18,814.00 |
| Net Debt | 11,725.00 |
| Equity (Book Value) | -7.63M |
| Book Value Per Share | -0.13 |
| Working Capital | -27,829.00 |
Cash Flow
CTT Pharmaceutical Holdings, Inc. produced -62,934.00 in operating cash flow over the past twelve months. After subtracting -3,952.00 in capital expenditures, free cash flow totaled -66,886.00 - equivalent to 0.00 per share.
| Operating Cash Flow | -62,934.00 |
| Capital Expenditures | -3,952.00 |
| Free Cash Flow | -66,886.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.65 |
| FCF Yield | -1.48 |
Stock Splits
CTT Pharmaceutical Holdings, Inc.'s most recent stock split took place on August 28, 2015 with a 10:1 split ratio.
| Last Split Date | 8/28/2015 |
| Split Ratio | 10:1 |
Scores
CTT Pharmaceutical Holdings, Inc. posts an Altman Z-Score of -1,541.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1,541.61 |